Gainers
- Magenta Therapeutics (NASDAQ:MGTA) stock rose 41.3% to $0.8 during Thursday's after-market session. Trading volume for this security closed at 2.9 million, accounting for 164.9% of its average full-day volume over the last 100 days. The company's market cap stands at $48.3 million.
- INVO Bioscience (NASDAQ:INVO) stock rose 14.79% to $0.69. The market value of their outstanding shares is at $8.3 million.
- Nymox Pharmaceutical (NASDAQ:NYMX) stock increased by 11.11% to $0.5. The market value of their outstanding shares is at $45.2 million.
- Aspira Womens Health (NASDAQ:AWH) stock increased by 10.9% to $0.49. Aspira Womens Health's trading volume hit 117.9K shares by close, accounting for 53.9% of its average volume over the last 100 days. The market value of their outstanding shares is at $60.8 million.
- Processa Pharma (NASDAQ:PCSA) stock moved upwards by 5.0% to $1.05. The market value of their outstanding shares is at $16.7 million.
- Plus Therapeutics (NASDAQ:PSTV) stock moved upwards by 5.0% to $0.43. The company's market cap stands at $14.4 million.
Losers
- Avalo Therapeutics (NASDAQ:AVTX) shares declined by 23.4% to $3.08 during Thursday's after-market session. The market value of their outstanding shares is at $28.9 million.
- Cellectis (NASDAQ:CLLS) shares fell 17.18% to $2.7. The company's market cap stands at $123.0 million.
- SILO Pharma (NASDAQ:SILO) stock fell 12.42% to $2.68. This security traded at a volume of 75.5K shares come close, making up 17.0% of its average volume over the last 100 days. The market value of their outstanding shares is at $8.4 million.
- MEI Pharma (NASDAQ:MEIP) shares declined by 7.96% to $0.31. The market value of their outstanding shares is at $40.8 million.
- Biophytis (NASDAQ:BPTS) stock declined by 7.79% to $0.65. Trading volume for this security closed at 11.8 million, accounting for 9508.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $13.3 million. As per the news, the H1 earnings report came out 2 days ago.
- Virpax Pharmaceuticals (NASDAQ:VRPX) shares declined by 7.41% to $1.0. The company's market cap stands at $11.7 million. See Also:
This article was generated by Benzinga's automated content engine and reviewed by an editor.